BPH-QL9-UROLIFE (Benign Prostatic Hypertrophy Health-related Quality of Life)

Developed by:
Bertrand Lukacs and Sanofi-Aventis (France)

Objective:
To assess the quality of life of patients with benign prostatic hyperplasia

Copyright:
Sanofi-Aventis. All rights reserved.

Reference publication:
Lukacs B, Leplege A, McCarthy C, Comet D. Symptom evaluation, quality of life and sexuality. Appendix A. Construction and validation of a BPH specific health related quality of life scale (with special attention to sexuality), for medical outcome research studies. In: Cockett A.T.K et al, Editors. Proceedings of the 2nde International Consultation on Benign Prostatic Hyperplasia (BPH), in Paris. SCI Jersey 1993: 139-143


Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Authors are detailed.


2. Access fees:

Authors' royalty fee: the use of UROLIFE in commercial studies is subject to Authors' royalty fees, of an amount 1000 €* per study and per language version requested.

Other specific conditions requested by the Authors are detailed in the User Agreement.

Distribution fees is requested according to the study design and context of use of the questionnaire:

1. In not-funded academic research (1) and individual clinical practice: free of charge
2. In funded academic research (2): 300 €* per study + an additional 50 €* per language version requested.
3. In commercial studies (3) involving "for-profit" organizations: 600 €* per study + an additional 250 €* per language version requested.

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:

Review Copy in US English available. Please click here to access


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75 -
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on UROLIFE on PROQOLID

[ BACK ]